The Anti-histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits SARS-CoV-2 Infection in Reconstituted Human Nasal Tissue In Vitro
R. Konrat, H. Papp, V. Szijarto, T. Gesell, G. Nagy, M. Madai, S. Zeghbib, A. Kuczmog, Z. Lanszki, Z. Helyes, G. Kemenesi, F. Jakab, E. Nagy
This paper identifies azelastine, an anti-histamine drug, as a potential inhibitor of SARS-CoV-2 infection through computational repurposing and in vitro testing in human nasal tissue.
bioRxiv · Sep 15, 2020 · PreprintMicrobiology